What is HH Biotechnology Holdings Company (HHBT) stock price today?

HH Biotechnology Holdings Company (HHBT) is currently trading at $0.00.

What is HHBT P/E ratio?

HH Biotechnology Holdings Company's P/E ratio is 0.00. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is HHBT return on equity (ROE)?

HH Biotechnology Holdings Company's return on equity (ROE) is 7.14%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is HH Biotechnology Holdings Company's market cap?

HH Biotechnology Holdings Company has a market capitalization of $1406.

OTC · Real Estate - Services

HH Biotechnology Holdings Company (HHBT) Stock

$0.00 OTC: HHBT Real Estate

Valuation

Metric	Value
Price	$0.00
Market Cap	$1406
P/E Ratio	0.00
P/B Ratio	0.00
P/S Ratio	0.00
EPS (TTM)	$0.00
52-Week High	$0.00
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	7.14%
ROA	4.35%
ROCE	7.41%
Gross Margin	37.50%
Operating Margin	37.50%
Net Margin	25.00%
Debt/Equity	0.18
Current Ratio	2.20

Annual Financials (USD)

Metric	2015
Revenue	$8.0M
Operating Profit	$3.0M
Net Profit	$2.0M
EPS	$0.18
Op Margin	38.8%

Balance Sheet (USD)

Metric	2015
Total Assets	$46.0M
Total Liabilities	$18.0M
Cash	$10.0M
Borrowings	$5.0M

Cash Flow (USD)

Metric	2015
Operating Cash Flow	$4.0M
Investing Cash Flow	$0
Financing Cash Flow	$6.0M
Net Cash Flow	$1.0M
Free Cash Flow	$4.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-0.95
FCF Yield	251178.09%
Quick Ratio	2.32
Interest Coverage	3.54
Return 1Y	-50.00%
Return 3Y	-66.67%
Return 5Y	-99.86%

Ownership

Insiders Held80.77%

Institutions Held0.00%

Institutions Float Held0.00%

Peer Comparison

Ticker	Price	Change	Market Cap	Div Yield
ACANAmeriCann, Inc.	$0.00	—	$2439	0.00%
AGTKAgritek Holdings, Inc.	$0.00	—	$5436	0.00%
BRERBresler & Reiner, Inc.	$0.00	—	$6025	0.00%
COWPPCanal Capital Corporation PFD EXCH $1.30	$0.00	—	$43	0.00%
CRXPFVert Infrastructure Ltd.	$0.00	—	$115	0.00%

About HH Biotechnology Holdings Company

HH Biotechnology Holdings Company operates within the health and green industries. Its primary activities include the cultivation and distribution of macadamia nuts, which are then utilized in a broad spectrum of products, including foodstuffs, culinary oils, wellness items, personal care products, and cosmetic formulations. The entity, originally established in 1987, was previously named Great China International Holdings, Inc. before rebranding to HH Biotechnology Holdings Company in August 2016. Its corporate headquarters are situated in Shenyang, People's Republic of China.

HH Biotechnology Holdings Company (HHBT) stock trades at $0.00 with a market capitalization of $1406. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, HH Biotechnology Holdings Company generates a return on equity (ROE) of 7.14%, return on capital employed of 7.41%, an operating margin of 37.50%, a net profit margin of 25.00%.

Official website: www.greatchinaholdings.com